CLINICAL_TRIALS
trial_result
· 2014-01-20
Clinical Trial Update: Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease [Phase 2]
Summary
Phase 2 trial assessing GWP42003 effects on liver fat in fatty liver disease completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GW Research Ltd | Conditions: Fatty Liver | Phase 2 | Status: COMPLETED | Results posted: 2014-01-20